Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer

NCT00756951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis
Head and Neck Cancer

Interventions

DRUG: Placebo
DRUG: SCV-07
DRUG: SCV-07

Sponsor

SciClone Pharmaceuticals